Veronica Skvortsova answered the letter of Russian Orthodox Church in the Ministry of Public Health and Social Development of Russia
The new bill «About biomedical cellular technologies» does not allow use of fabrics of an embryo (fruit) for preparation of the cellular lines which are a part of cellular products. The deputy minister of health care and social development of the Russian Federation Veronica Skvortsova so commented on the appeal to department Russian orthodox churches (Russian Orthodox Church) with the offer to consider an embryo as the person and to impose an absolute ban on receiving and use of embryonic fabrics and cages in a science and medicine about which we reported earlier.
Skvortsova told that «the bill allows preparation of cellular lines for production of a cellular product with use of cages of covers of a fruit of the person, allocated of a placenta, вартониева jelly of an umbilical cord and an umbilical blood of the person after normal childbirth». Their use is more proved from the moral and ethical point of view, Skvortsova considers. For cellular technologies are not allowed for use and sexual cages. However it does not concern approaches to ekstrakorporalny fertilisation (EKO) as the document does not extend on auxiliary reproductive technologies. Cellular technologies – one of the most perspective directions of biomedicine in the world, capable in the future to provide effective therapy of a large number of diseases, including considered now incurable. At the same time, legal regulation in the field of biomedical cellular technologies in Russia does not carry system character and has a number of gaps.
Skvortsova paid attention to one problem – use of suspensions of not cultivated cages, and also changes of fragments of fabrics in the medical purposes. Some scientists state fears that after the introduction of the law in force carrying out the advanced development becomes impossible, and our science will be rejected far back. «These fears are groundless, – Skvortsova is sure. – The draft of the federal law does not contain any restrictions of actually research activity and, therefore, cannot be an obstacle in a way of development of medical and biological sciences». A problem only that the transition mechanism from laboratory experiment to application of cellular products for the person remains up to the end not clear.« For permission to clinical research of a cellular product it is necessary to prove its safety for an organism of the recipient and his posterity, having excluded all possible risks – regenerations of a cellular material in a tumor, infections with an infection, entering into an organism of toxin, change of genes or chromosomes of the person and others», – explained the deputy minister.